• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经前综合征与非酒精性脂肪性肝病:基于性别医学的新方法。

Premenopausal Syndrome and NAFLD: A New Approach Based on Gender Medicine.

作者信息

Carrieri Livianna, Osella Alberto Ruben, Ciccacci Fausto, Giannelli Gianluigi, Scavo Maria Principia

机构信息

Personalized Medicine Laboratory, National Institute of Gastroenterology IRCCS "S. de Bellis" Research Hospital, Via Turi 27, 70013 Castellana Grotte, Italy.

Laboratory of Epidemiology and Biostatistics, National Institute of Gastroenterology IRCCS "S. de Bellis" Research Hospital, Via Turi 27, 70013 Castellana Grotte, Italy.

出版信息

Biomedicines. 2022 May 20;10(5):1184. doi: 10.3390/biomedicines10051184.

DOI:10.3390/biomedicines10051184
PMID:35625920
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9138606/
Abstract

Non-alcoholic fatty liver disease (NAFLD) is a multifactorial condition that affects 25% of the world's population. There is a clear difference in both geographical distribution and sex in childbearing age. These differences are reduced when women become older and senescence begins. The factors that affect the likelihood of developing NAFLD in a premenopausal woman are an imbalance of sex hormones (especially in estradiol and androgen), microbiome dysregulation, insulin resistance, early menarche, the length of time that the woman breastfeeds for and polycystic ovarian syndrome (PCOS). The aim of this review is to identify various physical ailments that may not appear to be serious to young women but that then affect the onset of NAFLD in perimenopause and can degenerate into NASH. These conditions should also be considered in future clinical management, as well as in research opportunities, in order to customize the monitoring and treatment of NAFLD, considering gender medicine for those women who had early metabolic symptoms that were not considered to be significant at the time.

摘要

非酒精性脂肪性肝病(NAFLD)是一种影响全球25%人口的多因素疾病。在地理分布和育龄期性别方面存在明显差异。当女性年龄增长并开始衰老时,这些差异会减小。影响绝经前女性患NAFLD可能性的因素包括性激素失衡(尤其是雌二醇和雄激素)、微生物群失调、胰岛素抵抗、初潮过早、母乳喂养时间长短以及多囊卵巢综合征(PCOS)。本综述的目的是识别各种对年轻女性看似不严重,但随后会影响围绝经期NAFLD发病并可能恶化为非酒精性脂肪性肝炎(NASH)的身体疾病。在未来的临床管理以及研究机会中,也应考虑这些情况,以便针对那些当时被认为不严重的早期代谢症状的女性,根据性别医学定制NAFLD的监测和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c44/9138606/b00503ecf32d/biomedicines-10-01184-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c44/9138606/802a404da2bf/biomedicines-10-01184-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c44/9138606/1c6de1a8ffe6/biomedicines-10-01184-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c44/9138606/8c4a23dfc740/biomedicines-10-01184-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c44/9138606/6fc376f43f65/biomedicines-10-01184-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c44/9138606/1e7bb1832f62/biomedicines-10-01184-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c44/9138606/b00503ecf32d/biomedicines-10-01184-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c44/9138606/802a404da2bf/biomedicines-10-01184-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c44/9138606/1c6de1a8ffe6/biomedicines-10-01184-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c44/9138606/8c4a23dfc740/biomedicines-10-01184-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c44/9138606/6fc376f43f65/biomedicines-10-01184-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c44/9138606/1e7bb1832f62/biomedicines-10-01184-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c44/9138606/b00503ecf32d/biomedicines-10-01184-g006.jpg

相似文献

1
Premenopausal Syndrome and NAFLD: A New Approach Based on Gender Medicine.绝经前综合征与非酒精性脂肪性肝病:基于性别医学的新方法。
Biomedicines. 2022 May 20;10(5):1184. doi: 10.3390/biomedicines10051184.
2
NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.非酒精性脂肪性肝病作为一种性别差异疾病:性别和生殖状态在非酒精性脂肪性肝病发生发展及内在心血管风险中的作用
Adv Ther. 2017 Jun;34(6):1291-1326. doi: 10.1007/s12325-017-0556-1. Epub 2017 May 19.
3
Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis.多囊卵巢综合征妇女的非酒精性脂肪性肝病:系统评价和荟萃分析。
J Endocrinol Invest. 2017 Dec;40(12):1279-1288. doi: 10.1007/s40618-017-0708-9. Epub 2017 Jun 13.
4
Nonalcoholic fatty liver disease and polycystic ovary syndrome.非酒精性脂肪性肝病与多囊卵巢综合征
World J Gastroenterol. 2014 Jul 14;20(26):8351-63. doi: 10.3748/wjg.v20.i26.8351.
5
Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.非酒精性脂肪性肝病与多囊卵巢综合征女性的胰岛素抵抗及脂质堆积产物相关。
Hum Reprod. 2016 Jun;31(6):1347-53. doi: 10.1093/humrep/dew076. Epub 2016 Apr 12.
6
Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease.非酒精性脂肪性肝病的绝经前妇女多囊卵巢综合征的患病率增加。
Eur J Endocrinol. 2015 Dec;173(6):739-47. doi: 10.1530/EJE-15-0567. Epub 2015 Sep 4.
7
Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens.非酒精性脂肪性肝病在绝经前、绝经后和多囊卵巢综合征妇女中的流行情况。雌激素的作用。
Ann Hepatol. 2010 Oct-Dec;9(4):402-9.
8
Non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism.多囊卵巢综合征女性的非酒精性脂肪性肝病——临床和代谢方面以及脂蛋白脂肪酶基因多态性
Endokrynol Pol. 2014;65(6):416-21. doi: 10.5603/EP.2014.0058.
9
Non-alcoholic fatty liver disease in polycystic ovarian syndrome in Indian women.印度女性多囊卵巢综合征中的非酒精性脂肪性肝病。
J Obstet Gynaecol. 2022 Jul;42(5):957-961. doi: 10.1080/01443615.2021.1969346. Epub 2021 Oct 23.
10
The hepato-ovarian axis: genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndrome.肝-卵巢轴:非酒精性脂肪性肝病与多囊卵巢综合征之间因果关联的遗传证据。
BMC Med. 2023 Feb 20;21(1):62. doi: 10.1186/s12916-023-02775-0.

引用本文的文献

1
Targeted Redox Regulation α-Ketoglutarate Dehydrogenase Complex for the Treatment of Human Diseases.用于治疗人类疾病的靶向氧化还原调节α-酮戊二酸脱氢酶复合物
Cells. 2025 Apr 29;14(9):653. doi: 10.3390/cells14090653.
2
The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease.亚太肝脏研究协会代谢功能障碍相关脂肪性肝病诊断和管理临床实践指南
Hepatol Int. 2025 Apr;19(2):261-301. doi: 10.1007/s12072-024-10774-3. Epub 2025 Feb 27.
3
Metabolic Syndrome Nonalcoholic Steatohepatitis Male Mouse With Adeno-Associated Viral Renin as a Novel Model for Heart Failure With Preserved Ejection Fraction.

本文引用的文献

1
Androgens, Endometriosis and Pain.雄激素、子宫内膜异位症与疼痛。
Front Reprod Health. 2021 Dec 3;3:792920. doi: 10.3389/frph.2021.792920. eCollection 2021.
2
A Low Glycemic Index Mediterranean Diet Combined with Aerobic Physical Activity Rearranges the Gut Microbiota Signature in NAFLD Patients.低升糖指数地中海饮食结合有氧运动可重塑非酒精性脂肪肝患者的肠道微生物组特征。
Nutrients. 2022 Apr 23;14(9):1773. doi: 10.3390/nu14091773.
3
Long or Irregular Menstrual Cycles and Risk of Prevalent and Incident Nonalcoholic Fatty Liver Disease.
以腺相关病毒肾素构建的代谢综合征非酒精性脂肪性肝炎雄性小鼠作为射血分数保留的心力衰竭新模型。
J Am Heart Assoc. 2024 Dec 3;13(23):e035894. doi: 10.1161/JAHA.124.035894. Epub 2024 Nov 22.
4
Leisure-Time Physical Activity, Time Spent Sitting and Risk of Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study in Puglia.闲暇时间体力活动、久坐时间与非酒精性脂肪肝疾病风险:普利亚地区的一项横断面研究。
J Gen Intern Med. 2024 Nov;39(14):2788-2796. doi: 10.1007/s11606-024-08804-9. Epub 2024 May 28.
5
Towards precision medicine in non-alcoholic fatty liver disease.迈向非酒精性脂肪性肝病的精准医学
Rev Endocr Metab Disord. 2023 Oct;24(5):885-899. doi: 10.1007/s11154-023-09820-6. Epub 2023 Jul 21.
月经周期过长或不规律与非酒精性脂肪性肝病现患和发病风险的关系。
J Clin Endocrinol Metab. 2022 May 17;107(6):e2309-e2317. doi: 10.1210/clinem/dgac068.
4
Gut microbiota and butyrate contribute to nonalcoholic fatty liver disease in premenopause due to estrogen deficiency.肠道微生物群和丁酸盐导致绝经前雌激素缺乏的非酒精性脂肪性肝病。
PLoS One. 2022 Feb 2;17(2):e0262855. doi: 10.1371/journal.pone.0262855. eCollection 2022.
5
Prevalence, Risk Factors, and Pathophysiology of Nonalcoholic Fatty Liver Disease (NAFLD) in Women with Polycystic Ovary Syndrome (PCOS).多囊卵巢综合征(PCOS)女性中非酒精性脂肪性肝病(NAFLD)的患病率、危险因素及病理生理学
Biomedicines. 2022 Jan 7;10(1):131. doi: 10.3390/biomedicines10010131.
6
Gut Microbiota-Related Cellular and Molecular Mechanisms in the Progression of Nonalcoholic Fatty Liver Disease.肠道微生物群相关的细胞和分子机制在非酒精性脂肪性肝病进展中的作用。
Cells. 2021 Oct 2;10(10):2634. doi: 10.3390/cells10102634.
7
Gut microbiome and metabolic response in non-alcoholic fatty liver disease.肠道微生物组与非酒精性脂肪性肝病的代谢反应。
Clin Chim Acta. 2021 Dec;523:304-314. doi: 10.1016/j.cca.2021.10.014. Epub 2021 Oct 16.
8
Beyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology.超越 X 因素:性激素在非酒精性脂肪性肝病发病机制中的相关性。
Cells. 2021 Sep 21;10(9):2502. doi: 10.3390/cells10092502.
9
Nonalcoholic fatty liver disease and the risk of insulin-requiring gestational diabetes.非酒精性脂肪性肝病与需胰岛素治疗的妊娠期糖尿病风险
Diabetol Metab Syndr. 2021 Aug 26;13(1):90. doi: 10.1186/s13098-021-00710-y.
10
The Association Between Breastfeeding and Nonalcoholic Fatty Liver Disease in Parous Women: A Nation-wide Cohort Study.母乳喂养与经产妇女非酒精性脂肪性肝病的相关性:一项全国性队列研究。
Hepatology. 2021 Dec;74(6):2988-2997. doi: 10.1002/hep.32034. Epub 2021 Jul 26.